AbbVie price target raised to $180 from $175 at Deutsche Bank
The Fly

AbbVie price target raised to $180 from $175 at Deutsche Bank

Deutsche Bank raised the firm’s price target on AbbVie (ABBV) to $180 from $175 and keeps a Hold rating on the shares. The company reported a quality Q3, but Emraclidine success looks already priced in, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App